Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Mar;67(3):1707-11.
doi: 10.1128/JVI.67.3.1707-1711.1993.

Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys

Affiliations

Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys

Y Yasutomi et al. J Virol. 1993 Mar.

Abstract

To assess the possible role of cytotoxic T lymphocytes (CTLs) in containing the spread of human immunodeficiency virus in acutely infected individuals, the temporal evolution of the virus-specific CD8+ lymphocyte response was defined in simian immunodeficiency virus of macaques (SIVmac)-infected rhesus monkeys. A brief period of SIVmac plasma antigenemia was seen 9 to 16 days following intravenous infection with SIVmac, ending as the absolute number of CD8+ peripheral blood lymphocytes (PBLs) increased. In a prospective assessment of the ability of CD8+ lymphocytes of these monkeys to suppress SIVmac replication in autologous PBLs, inhibitory activity was detected as early as 4 days, with a more pronounced effect 12 to 16 days following infection. SIVmac Gag- and Nef-specific CD8+ effector cell activities were demonstrable in PBLs of animals by 2 weeks following virus inoculation. In fact, SIVmac-specific CTL precursors were documented in the PBLs of rhesus monkeys 4 to 6 days after SIVmac infection. These studies indicate that AIDS virus-specific CD8+ CTLs are present in PBLs within days of infection and may play an important role in containing the early spread of virus.

PubMed Disclaimer

References

    1. Science. 1988 Apr 1;240(4848):64-6 - PubMed
    1. J Immunol. 1991 Jul 1;147(1):320-9 - PubMed
    1. J Exp Med. 1981 Aug 1;154(2):225-34 - PubMed
    1. N Engl J Med. 1982 Jul 1;307(1):7-13 - PubMed
    1. Science. 1985 Oct 4;230(4721):71-3 - PubMed

Publication types

MeSH terms